Rosemarie Raffen
Papers
1
Total Citations
541
H-Index
1
About
Rosemarie Raffen is a molecular biologist whose work has significantly advanced the field of recombinant protein production and purification. Her most impactful contribution is the development of a novel vector for high-throughput, ligation-independent cloning that incorporates a Tobacco Etch Virus (TEV) protease cleavage site. This foundational tool, detailed in her 2002 paper (541 citations), streamlined the process of generating soluble, tag-free proteins for structural and functional studies, becoming a standard method in laboratories worldwide. Raffen’s research focuses on optimizing expression systems and purification strategies, enabling efficient protein engineering for applications in drug discovery and structural biology. Her work has empowered researchers to overcome bottlenecks in protein production, accelerating discoveries in fields ranging from enzymology to vaccine development. With a citation count reflecting the enduring utility of her contributions, Raffen is recognized for providing a simple yet powerful solution that has shaped modern molecular cloning practices. Her legacy lies in enabling high-throughput approaches that continue to drive innovation in biotechnology and biomedical research.
Research Focus
Key Achievements
Top Papers
- 1